When will clinical trials finally reflect diversity?

Association BetweenCYP2C19Loss-of-Function Allele Status and Efficacy of Clopidogrel for Risk Reduction Among Patients With Minor Stroke or Transient Ischemic Attack

(2016) Yilong Wang et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

NUDT15 polymorphisms alter thiopurine metabolism and hematopoietic toxicity

(2016) Takaya Moriyama et al.   NATURE GENETICS

Racial/ethnic differences in drug disposition and response: Review of recently approved drugs

(2015) A Ramamoorthy et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

Heritage-Specific Mechanisms for Cancer Adverse Reactions: One Gene Does Not Explain the World

(2015) Todd C. Knepper et al.   JOURNAL OF CLINICAL ONCOLOGY

2014 FDA drug approvals

(2015) Asher Mullard   NATURE REVIEWS DRUG DISCOVERY

Clinical Pharmacogenetics Implementation Consortium Guidelines for CYP2C19 Genotype and Clopidogrel Therapy: 2013 Update

(2013) S A Scott et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

Efficient clinical trials in Japan: Bridging studies versus participation in global clinical trials

(2013) Mari Shirotani et al.   JOURNAL OF CLINICAL PHARMACOLOGY